"Designing Growth Strategies is in our DNA"

Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated, Viral Vector, mRNA, Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases {Hepatitis, Influenza, Human Papillomavirus, Measles/Mumps/Rubella, Rotavirus, Herpes Zoster}, and Bacterial Diseases {Meningococcal Disease, Pneumococcal Disease, Diphtheria/Tetanus/Pertussis}), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101769

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Pipeline Analysis, By Key Players
    3. Technological Advancements in the Vaccines Market
    4. Incidence/Prevalence of Key Diseases, 2023
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    6. COVID-19 Impact on the Market
  5. Global Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Viral Vector
      5. mRNA
      6. Toxoid
      7. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Viral Vector
      5. mRNA
      6. Toxoid
      7. Others
    2. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
        1. By Type
      2. Canada
        1. By Type
  7. Europe Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Viral Vector
      5. mRNA
      6. Toxoid
      7. Others
    2. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K.
        1. By Type
      2. Germany
        1. By Type
      3. France
        1. By Type
      4. Spain
        1. By Type
      5. Italy
        1. By Type
      6. Scandinavia
        1. By Type
      7. Rest of Europe
        1. By Type
  8. Asia Pacific Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Viral Vector
      5. mRNA
      6. Toxoid
      7. Others
    2. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
        1. By Type
      2. China
        1. By Type
      3. India
        1. By Type
      4. Australia
        1. By Type
      5. Southeast Asia
        1. By Type
      6. Rest of Asia Pacific
        1. By Type
  9. Latin America Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
    2. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
        1. By Type
      2. Mexico
        1. By Type
      3. Rest of Latin America
        1. By Type
  10. Middle East & Africa Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast  – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Viral Vector
      5. mRNA
      6. Toxoid
      7. Others
    2. Market Analysis, Insights and Forecast  – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast  – By Disease Indication
      1. Viral Diseases
        1. Hepatitis
        2. Influenza
        3. Human Papillomavirus
        4. Measles/Mumps/Rubella
        5. Rotavirus
        6. Herpes Zoster
        7. Others
      2. Bacterial Diseases
        1. Meningococcal Disease
        2. Pneumococcal Disease
        3. Diphtheria/Tetanus/Pertussis
        4. Others
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC Countries
        1. By Type
      2. South Africa
        1. By Type
      3. Rest of Middle East & Africa
        1. By Type
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Bavarian Nordic
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. CSL Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Mitsubishi Chemical Group Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. AstraZeneca
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. EMERGENT
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. BIKEN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Vaccines Market Value Share (%), by Type, 2023 & 2032

Figure 3: Global Vaccines Market Value Share (%), by Route of Administration, 2023 & 2032

Figure 4: Global Vaccines Market Value Share (%), by Disease Indication, 2023 & 2032

Figure 5: Global Vaccines Market Value Share (%), by Age Group, 2023 & 2032

Figure 6: Global Vaccines Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 7: Global Vaccines Market Value (USD billion), by Region, 2023 & 2032

Figure 8: North America Vaccines Market Value (USD billion), by Type, 2023 & 2032

Figure 9: North America Vaccines Market Value Share (%), by Type, 2023

Figure 10: North America Vaccines Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 11: North America Vaccines Market Value Share (%), by Route of Administration, 2023

Figure 12: North America Vaccines Market Value (USD billion), by Disease Indication, 2023 & 2032

Figure 13: North America Vaccines Market Value Share (%), by Disease Indication, 2023

Figure 14: North America Vaccines Market Value (USD billion), by Age Group, 2023 & 2032

Figure 15: North America Vaccines Market Value Share (%), by Age Group, 2023

Figure 16: North America Vaccines Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 17: North America Vaccines Market Value Share (%), by Distribution Channel, 2023

Figure 18: North America Vaccines Market Value (USD billion), By Country, 2023 & 2032

Figure 19: North America Vaccines Market Value Share (%), By Country, 2023

Figure 20: Europe Vaccines Market Value (USD billion), by Type, 2023 & 2032

Figure 21: Europe Vaccines Market Value Share (%), by Type, 2023

Figure 22: Europe Vaccines Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 23: Europe Vaccines Market Value Share (%), by Route of Administration, 2023

Figure 24: Europe Vaccines Market Value (USD billion), by Disease Indication, 2023 & 2032

Figure 25: Europe Vaccines Market Value Share (%), by Disease Indication, 2023

Figure 26: Europe Vaccines Market Value (USD billion), by Age Group, 2023 & 2032

Figure 27: Europe Vaccines Market Value Share (%), by Age Group, 2023

Figure 28: Europe Vaccines Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 29: Europe Vaccines Market Value Share (%), by Distribution Channel, 2023

Figure 30: Europe Vaccines Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 31: Europe Vaccines Market Value Share (%), By Country/ Sub-region, 2023

Figure 32: Asia Pacific Vaccines Market Value (USD billion), by Type, 2023 & 2032

Figure 33: Asia Pacific Vaccines Market Value Share (%), by Type, 2023

Figure 34: Asia Pacific Vaccines Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 35: Asia Pacific Vaccines Market Value Share (%), by Route of Administration, 2023

Figure 36: Asia Pacific Vaccines Market Value (USD billion), by Disease Indication, 2023 & 2032

Figure 37: Asia Pacific Vaccines Market Value Share (%), by Disease Indication, 2023

Figure 38: Asia Pacific Vaccines Market Value (USD billion), by Age Group, 2023 & 2032

Figure 39: Asia Pacific Vaccines Market Value Share (%), by Age Group, 2023

Figure 40: Asia Pacific Vaccines Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 41: Asia Pacific Vaccines Market Value Share (%), by Distribution Channel, 2023

Figure 42: Asia Pacific Vaccines Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 43: Asia Pacific Vaccines Market Value Share (%), By Country/ Sub-region, 2023

Figure 44: Latin America Vaccines Market Value (USD billion), by Type, 2023 & 2032

Figure 45: Latin America Vaccines Market Value Share (%), by Type, 2023

Figure 46: Latin America Vaccines Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 47: Latin America Vaccines Market Value Share (%), by Route of Administration, 2023

Figure 48: Latin America Vaccines Market Value (USD billion), by Disease Indication, 2023 & 2032

Figure 49: Latin America Vaccines Market Value Share (%), by Disease Indication, 2023

Figure 50: Latin America Vaccines Market Value (USD billion), by Age Group, 2023 & 2032

Figure 51: Latin America Vaccines Market Value Share (%), by Age Group, 2023

Figure 52: Latin America Vaccines Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 53: Latin America Vaccines Market Value Share (%), by Distribution Channel, 2023

Figure 54: Latin America Vaccines Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 55: Latin America Vaccines Market Value Share (%), By Country/ Sub-region, 2023

Figure 56: Middle East & Africa Vaccines Market Value (USD billion), by Type, 2023 & 2032

Figure 57: Middle East & Africa Vaccines Market Value Share (%), by Type, 2023

Figure 58: Middle East & Africa Vaccines Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 59: Middle East & Africa Vaccines Market Value Share (%), by Route of Administration, 2023

Figure 60: Middle East & Africa Vaccines Market Value (USD billion), by Disease Indication, 2023 & 2032

Figure 61: Middle East & Africa Vaccines Market Value Share (%), by Disease Indication, 2023

Figure 62: Middle East & Africa Vaccines Market Value (USD billion), by Age Group, 2023 & 2032

Figure 63: Middle East & Africa Vaccines Market Value Share (%), by Age Group, 2023

Figure 64: Middle East & Africa Vaccines Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 65: Middle East & Africa Vaccines Market Value Share (%), by Distribution Channel, 2023

Figure 66: Middle East & Africa Vaccines Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 67: Middle East & Africa Vaccines Market Value Share (%), By Country/ Sub-region, 2023

Figure 68: Global Vaccines Market Share (%), By Company, 2023

Table 1: Global Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 2: Global Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 3: Global Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032

Table 4: Global Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032

Table 5: Global Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032

Table 6: Global Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 7: Global Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 8: Global Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 10: North America Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 11: North America Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032

Table 12: North America Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032

Table 13: North America Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032

Table 14: North America Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 15: North America Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 16: North America Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 17: U.S. Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 18: Canada Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 19: Europe Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 20: Europe Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 21: Europe Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032

Table 22: Europe Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032

Table 23: Europe Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032

Table 24: Europe Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 25: Europe Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 26: Europe Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 27: Germany Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 28: France Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 29: U.K. Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 30: Italy Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 31: Spain Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 32: Scandinavia Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 33: Rest of Europe Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 34: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 35: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 36: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032

Table 37: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032

Table 38: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032

Table 39: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 40: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 41: Asia Pacific Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 42: India Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 43: China Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 44: Japan Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 45: Australia Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 46: South East Asia Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 47: Rest of Asia Pacific Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 48: Latin America Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 49: Latin America Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 50: Latin America Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032

Table 51: Latin America Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032

Table 52: Latin America Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032

Table 53: Latin America Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 54: Latin America Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 55: Latin America Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 56: Brazil Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 57: Mexico Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 58: Rest of Latin America Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 59: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 60: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 61: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032

Table 62: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032

Table 63: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032

Table 64: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 65: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 66: Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 67: GCC Countries Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 68: South Africa Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 69: Rest of Middle East & Africa Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032

Vaccines Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 219
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase